Assenagon Asset Management S.A. Lowers Stock Holdings in Tenet Healthcare Corporation $THC

Assenagon Asset Management S.A. lessened its holdings in Tenet Healthcare Corporation (NYSE:THC) by 82.7% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 62,808 shares of the company’s stock after selling 300,946 shares during the period. Assenagon Asset Management S.A. owned 0.07% of Tenet Healthcare worth $12,481,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Norges Bank bought a new position in shares of Tenet Healthcare during the second quarter worth $206,981,000. Eminence Capital LP bought a new stake in shares of Tenet Healthcare in the third quarter worth about $225,263,000. Boston Partners lifted its position in shares of Tenet Healthcare by 38.8% in the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares in the last quarter. AQR Capital Management LLC boosted its stake in Tenet Healthcare by 62.3% during the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after buying an additional 720,160 shares during the last quarter. Finally, Alliancebernstein L.P. increased its stake in Tenet Healthcare by 375.7% in the 2nd quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after acquiring an additional 624,125 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on THC. Wall Street Zen upgraded Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Sunday, March 1st. Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Mizuho boosted their price objective on Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research note on Thursday, March 12th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Finally, Jefferies Financial Group boosted their target price on Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $250.56.

Tenet Healthcare Trading Down 1.8%

NYSE:THC opened at $192.01 on Friday. The firm has a market cap of $16.70 billion, a P/E ratio of 12.40, a P/E/G ratio of 0.94 and a beta of 1.39. The company has a debt-to-equity ratio of 2.18, a quick ratio of 1.68 and a current ratio of 1.76. Tenet Healthcare Corporation has a one year low of $109.82 and a one year high of $247.21. The firm has a 50-day simple moving average of $213.80 and a 200-day simple moving average of $205.12.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, beating analysts’ consensus estimates of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter last year, the company earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts anticipate that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other news, EVP Thomas W. Arnst sold 8,000 shares of Tenet Healthcare stock in a transaction on Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the completion of the sale, the executive vice president directly owned 12 shares in the company, valued at approximately $2,866.20. The trade was a 99.85% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the company’s stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total value of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 46,517 shares of company stock worth $10,943,111. Insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.